Dorman Products vs Gentex
Add, change or remove companies; up to four.
The short version
- Gentex is the larger business, with $2.5B of revenue in fiscal 2025 against $2.1B for Dorman Products.
- Gentex grew revenue faster (9.6%, against 6.0%).
- Gentex kept more of each dollar of sales as operating profit (18.7% operating margin, against 14.1%).
- Gentex turned more of its sales into free cash flow (18.1% FCF margin, against 3.6%).
- Gentex earned a higher return on the capital invested in it (17.4%, against 12.4%).
- Investors pay more for each dollar of Dorman Products’s earnings: a P/E of 17.3x against 10.9x for Gentex.
| Latest fiscal year | DORM · FY25 | GNTX · FY25 |
|---|---|---|
| Size | ||
| Market cap | $3.8B | $4.3B |
| Revenue | $2.1B | $2.5B |
| Free cash flow | $75.7M | $458M |
| Net income | $204M | $385M |
| Growth | ||
| Revenue growth | 6.0% | 9.6% |
| 5-year growth | 14.3% | 8.5% |
| Share count change | −0.7% | −3.6% |
| Profitability | ||
| Gross margin | 42.1% | 34.2% |
| Operating margin | 14.1% | 18.7% |
| Net margin | 9.6% | 15.2% |
| FCF margin | 3.6% | 18.1% |
| Return on capital | 12.4% | 17.4% |
| Return on equity | 14.7% | 15.5% |
| Balance sheet | ||
| Net debt | $391M | −$147M |
| Net debt / EBITDA | 1.2x | −0.3x |
| Dividends and buybacks | $0.0M | $422M |
| Valuation & quality | ||
| P/E | 17.3x | 10.9x |
| Piotroski F-score | 8 | 6 |
Revenue
FY16
DORM $860M
GNTX $1.7B
FY17
DORM $903M
GNTX $1.8B
FY18
DORM $974M
GNTX $1.8B
FY19
DORM $991M
GNTX $1.9B
FY20
DORM $1.1B
GNTX $1.7B
FY21
DORM $1.3B
GNTX $1.7B
FY22
DORM $1.7B
GNTX $1.9B
FY23
DORM $1.9B
GNTX $2.3B
FY24
DORM $2.0B
GNTX $2.3B
FY25
DORM $2.1B
GNTX $2.5B
DORM
GNTX
Operating margin
FY16
DORM 19.6%
GNTX 30.5%
FY17
DORM 19.5%
GNTX 29.2%
FY18
DORM 17.6%
GNTX 27.7%
FY19
DORM 10.7%
GNTX 26.3%
FY20
DORM 12.2%
GNTX 23.7%
FY21
DORM 12.8%
GNTX 23.7%
FY22
DORM 9.9%
GNTX 19.3%
FY23
DORM 11.1%
GNTX 21.6%
FY24
DORM 14.6%
GNTX 19.9%
FY25
DORM 14.1%
GNTX 18.7%
DORM
GNTX
Free cash flow
FY16
DORM $101M
GNTX $356M
FY17
DORM $69.8M
GNTX $397M
FY18
DORM $52.0M
GNTX $466M
FY19
DORM $65.8M
GNTX $421M
FY20
DORM $137M
GNTX $413M
FY21
DORM $80.5M
GNTX $293M
FY22
DORM $3.8M
GNTX $192M
FY23
DORM $165M
GNTX $354M
FY24
DORM $192M
GNTX $354M
FY25
DORM $75.7M
GNTX $458M
DORM
GNTX
Return on capital
FY16
DORM —
GNTX 25.3%
FY17
DORM —
GNTX 29.7%
FY18
DORM —
GNTX 30.4%
FY19
DORM —
GNTX 27.9%
FY20
DORM —
GNTX 22.4%
FY21
DORM —
GNTX 22.3%
FY22
DORM 11.3%
GNTX 18.2%
FY23
DORM 10.6%
GNTX 21.6%
FY24
DORM 13.1%
GNTX 18.4%
FY25
DORM 12.4%
GNTX 17.4%
DORM
GNTX
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.